Dianthus Therapeutics, Inc. /DE/
DNTH
DELAYED 1 MONTH

12 insider filings · Latest: Jun 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 1, 2026Jun 2 11:00 PMSimrat RandhawaEVP, Head of R&D
Sale
26,530$90.62$2.4M4,000(D)

View →

May 8, 2026May 11 9:00 PMPaula SoteropoulosDirector
Sale
599$85.47$51.2K0(D)

View →

Mar 12, 2026Mar 14 12:30 AMMarino GarciaDirector, CEO AND PRESIDENT
Sale
122,918$81.49$10.0M0(D)

View →

Mar 12, 2026Mar 14 12:30 AMEdward CarrCHIEF ACCOUNTING OFFICER
Sale
43,682$81.49$3.6M0(D)

View →

Mar 12, 2026Mar 14 12:30 AMSimrat RandhawaEVP, Head of R&D
Sale
33,830$81.48$2.8M0(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 1, 2026Jun 2 11:00 PMSimrat RandhawaEVP, Head of R&D
Option Exercise
26,530$22.0796,875(D)

View →

May 21, 2026May 22 8:30 PMSteven J. RomanoDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMSimon ReadDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMAnne McgeorgeDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMAlison Frances LawtonDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMSujay KangoDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMJonathan ViolinDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMPaula SoteropoulosDirector
Grant/Award
6,090$89.636,090(D)

View →

May 8, 2026May 11 9:00 PMPaula SoteropoulosDirector
Option Exercise
599$8.440(D)

View →

Mar 12, 2026Mar 14 12:30 AMMarino GarciaDirector, CEO AND PRESIDENT
Option Exercise
122,918$6.7059,741(D)

View →

Mar 12, 2026Mar 14 12:30 AMEdward CarrCHIEF ACCOUNTING OFFICER
Option Exercise
43,682$22.0750,000(D)

View →

Mar 12, 2026Mar 14 12:30 AMSimrat RandhawaEVP, Head of R&D
Option Exercise
33,830$22.07106,250(D)

View →